Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2018

Open Access 01-12-2018 | Research article

Seroprevalence of transfusion-transmissible infections (HBV, HCV, syphilis and HIV) among prospective blood donors in a tertiary health care facility in Calabar, Nigeria; an eleven years evaluation

Authors: Henshaw Uchechi Okoroiwu, Ifeyinwa Maryann Okafor, Enosakhare Aiyudubie Asemota, Dorathy Chioma Okpokam

Published in: BMC Public Health | Issue 1/2018

Login to get access

Abstract

Background

Provision of constant and safe blood has been a public health challenge in Sub-Saharan Africa with high prevalence of transfusion-transmissible infections (TTIs). This study was aimed at determining the trend and seroprevalence of HBV, HCV, syphilis and HIV across the years within study among prospective blood donors at blood bank in University of Calabar Teaching Hospital (UCTH), Calabar, Nigeria.

Methods

A retrospective analysis of blood donor data from January 2005 to December 2016 was conducted in Blood Bank/Donor Clinic of University of Calabar Teaching Hospital, Calabar, Nigeria. Sera samples were screened for hepatitis B surface antigen (HBsAg), antibodies to hepatitis C virus (HCV), human immunodeficiency virus (HIV) 1 and 2 and Treponema pallidum using commercially available immunochromatic based kits.

Results

Out of the 24,979 screened prospective donors in the 2005–2016 study period, 3739 (14.96%) were infected with at least one infective agent. The overall prevalence of HBV, HCV, syphilis and HIV were 4.1, 3.6, 3.1 and 4.2%, respectively. During the period of study, the percentage of all transfusion-transmissible infections declined significantly with remarkable decline in HIV. The study showed male dominated donor pool (98.7%) with higher prevalence (4.2%) of transfusion-transmissible infections than in female donors (0.0%). Commercial donors constituted majority (62.0%) of the donors and as well had the highest prevalence of transfusion-transmissible infections. Majority (62.9%) of the donors were repeat donors.

Conclusion

HBV, HCV, syphilis and HIV have remained a big threat to safe blood transfusion in Nigeria and Sub-Saharan Africa at large. Strict adherence to selection criteria and algorithm of donor screening are recommended.
Literature
1.
Nilima S, Sawke GK, Chawla S. Seroprevalence of common transfusion-transmitted infections among blood donors. Peoples J Sci Res. 2010;3:5–7.
2.
Okafor MI, Akpotuzor JO, Ibanga IA. Prevalence of alpha and Beta Haemolysin antibodies among transfused adults in Nigeria. J Med Lab Sci. 2010;19:27–31.
3.
Tessema B, Yismaw G, Kassu A, et al. Seroprevalence of HIV, HBV, HCV and syphilis infections among blood donors at Gondar University teaching hospital, Northwest Ethiopia: declining trends over a period of five years. BMC Infect Dis. 2010;10:111.CrossRefPubMedPubMedCentral
4.
Aneke JC, Okocha CE. Blood transfusion safety; current states and challenges in Nigeria. Asian J Tranfus Sci. 2017;11(1):1–5.CrossRef
5.
National Blood Transfusion Service. Federal Ministry of Health Nigeria. The National Blood Policy. Nigeria: National Blood Transfusion Service Ministry of Health; 2006.
6.
Erhabor O, Adias TC, Mainasara AS. Provision of safe blood transfusion services in low income setting in West Africa, case study of Nigeria. Adv Med Biol. 2013;59:1–58.
7.
Barbara J, Eglin R. Introduction: transfusion-transmitted infection, then and now. In: Barbara J, Regan F, Contreras M, editors. Transfusion microbiology. New York: Cambridge University Press; 2008. p. 1–7.CrossRef
8.
9.
Fasola FA, Otegbayo IA. Post-transfusion hepatitis in sickle cell anemia retrospective-prospective analysis. Niger J Clin Pract. 2002;5:16–9.
10.
World Health Organization (WHO). Global hepatitis report 2017. Geneva: World health Organization. p. 2017.
11.
12.
13.
World Health Organization (WHO). Report on global sexually transmitted infection surveillance 2015. Geneva: World health Organization. p. 2015.
14.
15.
Tiwari BR, Ghimmire P, Karki S, et al. Seroprevalence of human immunodeficiency virus in Nepalese blood donors: a study from three regional blood transfusion services. Asian J Transfus Sci. 2008;2:66–8.CrossRefPubMedPubMedCentral
16.
Jasmin J, Vaidehi P, Kaushik B, et al. Seroprevalence of transfusion transmissible infections among blood donors in a tertiary care hospital. Int J Biol Med Res. 2012;3:1423–5.
17.
World Health Organization. Report on global sexually transmitted infection surveillance 2013. Geneva: WHODocument Production Services; 2014.
18.
O’Brien SF, Yi QL, Fan W, Scalia V, Kleinman SH, Vamvakas EC. Current incidence and estimated residual risk of transfusion-transmissible infections in donations made to Canadian blood services. Transfusion. 2007;47:316–25.CrossRefPubMed
19.
20.
Nwankwo E, Momodu I, Umar I, Musa B, Adeleke S. Seroprevalence of major blood-borne infections among blood donors in Kano, Nigeria. Turk J Med. 2012;42:337–41.
21.
Nagalo MB, Sanou M, Bisseye C, Kaboré MI, Nebie YK, Kienou K. Seroprevalence of human immunodeficiency virus, hepatitis B and C virus and syphilis among blood donors in Koudougou (Burkina Faso) in 2009. Blood Transfus. 2011;9:419–24.PubMedPubMedCentral
22.
Yusuf M, Alemayehu B. Seroprevalence of transfusion transmitted infection among blood donors of Jijiga blood bank, East Ethiopia; retrospective 4 years study. BMC Res Notes. 2016;9:129.CrossRef
23.
Uneke CJ, Ogbu O, Inyama PU, Anyanwu GI, Njoku MO, Idoko JH. Prevalence of hepatitis- B surface antigen among blood donors and immunodeficiency virus-infected patients in Jos Nigeria. Mem Inst Oswaldo Cruz. 2005;100:13–6.CrossRefPubMed
24.
Elkanah OS, Okoye AL, Debby-Sambo OE. Prevalence of hepatitis-B surface antigen among blood donors in Jalingo, Taraba state, Nigeria. Niger J Parasitol. 2013;34:119–22.
25.
Otegbayo JA, Fasola FO, Abja A. Prevalence of hepatitis-B surface antigen (HBsAg) and hepatitis B envelop antigen (HBeAg), risk factor of vital acquisition and serum transaminase among blood donors in Ibadan, Nigeria. Trop Gastroenterol. 2003;24:196–7.PubMed
26.
Ejele OA, Ojule AC. The prevalence of hepatitis-B surface antigen (HBsAg), among prospective donors and patients in Portharcourt, Nigeria. Niger J Med. 2004;13:336–8.PubMed
27.
Julius TD, Sylvanus K, Ireneous NS, Asebga PN, Ziem JB, Sagoe K. Prevalence of hepatitis B virus infection among blood donors at the tamale teaching hospital Ghana 2009. BMC Res Notes. 2012;5:115.CrossRef
28.
Takpo JB, Sam O, Diarra-Nama AJ. Status of blood safety in the WHO African region: report on the 2004 survey. Brazzaville Republic of the Congo: AFRO WHO; 2007.
29.
Julius MN, Patrick AN, Michel K, et al. Prevalence of hepatitis B virus infection among blood donors at the Younde military hospital, Cameroon. Microbiol Res Int. 2016;4:6–10.
30.
Bala JA, Kawo AH, Muktar MD, Sarki A, Magaji N, Aliyu IA, et al. Prevalence of hepatitis C infection among blood donors in some selected hospitals in Kano, Nigeria. Intern Res J Microbiol. 2012;3:21722.
31.
Nwannadi IA, Alao O, Shoaga L. Hepatitis C among blood donors in teaching hospital in north Central Nigeria. IOSR J Dental Med Sci. 2014;13:20–3.
32.
Erhabor O, Ejele OA, Nwanche CA. The risk of acquired hepatitis C virus infection among blood donors in Portharcourt: the question of blood safety in Nigeria. Niger J Clin Pract. 2006;9:18–21.PubMed
33.
Odenigbo C, Oguejiolor C, Okonkwo U, Asamugha A, Ezeh T, Okocha E. Prevalence of antibodies to hepatitis C virus in blood donors in Nnewi, south East Nigeria: in association with blood groups. Intern J Gastroenterol. 2011; 10:5580/1c70
34.
Dammulak OD, Piwuna TO, Joseph DE, Ogbenna AA, Kut SD, Godit P, et al. Hepatitis C virus antibody among blood donors: the experience in a Nigerian blood transfusion center. Glo Adv Res J Med Sci. 2013;2:108–13.
35.
Buseri FI, Muhibi MA, Jeremiah ZA. Seroepidemiology of transfusion transmissible infections among blood donors in Osogbo, south West Nigeria. Blood Transfus. 2009;7:293–7.PubMedPubMedCentral
36.
Kamande MW, Kibebe H, Mokua J. Prevalence of transfusion transmissible infections among blood donated at Nyeri satellite transfusion Centre in Kenya. IOSR J Pharm. 2016;6:20–30.CrossRef
37.
Walana W, Ahiaba S, Hokey P, Vicar EK, Acquah SEK, Der EM, et al. Seroprevalence of HIV, HBV and HCV among blood donors in Kintampo municipal hospitals, Ghana. Br Microbiol Res J. 2014;4(12):1491–9.CrossRef
38.
Chikwem JO, Mohammed I, Okara GC. Prevalence of transmissible blood infections among blood donors at the University of Maiduguri Teaching Hospital, Maiduguri, Nigeria. East Afr Med J. 1997;74:213–6.PubMed
39.
Salawu L, Bolarinwa RA, Adegunloye AB, et al. HBsAg, anti-HCV and VDRL in blood donors: prevalence and trends in the last three and a half years in a tertiary healthcare facility in Ile-Ife, Nigeria. Int J Med Med Sci. 2010;2:335–41.
40.
Andrew AA, William K, Henry A, et al. Prevalence of antibodies to syphilis among blood donors in Accra, Ghana. Jpn J Infect Dis. 2003;56:165–7.
41.
Erhabor O, Usman I, Wase A, et al. Prevalence of transfusion-transmissible HIV infection in Sokoto, north western Nigeia. Am J Microbiol Biotechnol. 2014;1:36–42.
42.
Imoru M, Eke C, Adegoke A. Prevalence of hepatitis B surface antigen (HBsAg), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) among blood donors in Kano state, Nigeria. J Med Lab Sci. 2003;12:59–63.
43.
Hassan A, Muktar HM, Mamman AI, et al. The incidence of HIV among blood donors in Kaduna, Nigeria. Afr Health Sci. 2008;8:60.PubMedPubMedCentral
44.
Okocha EC, Aneke JC, Ezeh TU, Ibeh NC, Nwosu GA, Okorie IO, et al. The epidemiology of transfusion-transmissible infections among blood donors in Nnewi, south-East Nigeria. Afr J Med Health Sci. 2015;14:125–9.CrossRef
45.
Kassim OD, Oyekale TO, Aneke JC, Durosinmi MA. Prevalence of seropositive blood donors for hepatitis B, C and HIV viruses at the Federal Medical Centre, ado-Ekiti Nigeria. Ann Trop Pathol. 2012;3:47–55.
46.
Unnikrishnan B, Rao P, Kumar N, Gati S, Prasad R, Armarnath A, et al. Profile of blood donors and reasons for deferral in coastal South India. Australas Med J. 2011;4(7):379–85.CrossRefPubMedPubMedCentral
47.
Zaheer HA, Saeed U, Waheed Y, Karimi S, Waheed U. Prevalence and trends of hepatitis B, hepatitis C and human immunodeficiency virus among blood donors in Islamabad, Pakistan 2005-2013. J Blood Disorders Transf. 2014;5(6):1–5.
48.
Noubiap JJ, Joko WY, Nansseu JRN, Tene UG, Siaka C. Sero-epidemiology of human immunodeficiency virus, hepatitis B and C virus and syphilis infections among first time donors in Edea, Cameroon. Int J Infect Dis. 2013;17(10):e832–7.CrossRefPubMed
49.
Birhaneselassie M. Prevalence of transfusion transmissible infections in donors in Ethiopian blood bank between 2009 and 2013 and donation factors that would improve the safety of the blood supply in underdeveloped countries. Lab Med. 2016;47(2):134–9.CrossRefPubMed
50.
Alvarado-Esquivel C, Rascon-Careaga A, Liesenfeld O. Seroprevalence and associated risk factors for toxoplasma gondii infection in healthy blood donors; a cross sectional study in senora, Mexico. Biomed Res Int. 2016;9597276:8.
51.
52.
Shaz BH, James AB, Hillyer KL, Shrelber GB, Hillyer CD. Demographic patterns of blood donors in and donations in a large metropolitan area. J Natl Med Assoc. 2011;103:351–7.CrossRefPubMed
53.
Damulak OD, Bolorunduro SO, Boman F, Bako L. Pattern of blood donors in Jos. Jos J Med. 2011;5(5):44–5.
54.
World Health Organization (WHO). Blood safety strategy for the African region. Brazzaville: World Health Organization, Regional Office for Africa (WHO AFR /RC51/9 Rev.1); 2002.
Metadata
Title
Seroprevalence of transfusion-transmissible infections (HBV, HCV, syphilis and HIV) among prospective blood donors in a tertiary health care facility in Calabar, Nigeria; an eleven years evaluation
Authors
Henshaw Uchechi Okoroiwu
Ifeyinwa Maryann Okafor
Enosakhare Aiyudubie Asemota
Dorathy Chioma Okpokam
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2018
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-018-5555-x

Other articles of this Issue 1/2018

BMC Public Health 1/2018 Go to the issue

Research article

The associations between employees’ risky drinking and sociodemographics, and implications for intervention needs

Research article

“I aspire to look and feel healthy like the posts convey”: engagement with fitness inspiration on social media and perceptions of its influence on health and wellbeing

Research article

Bibliometric analysis of global migration health research in peer-reviewed literature (2000–2016)

Research article

Cross-sectional and prospective associations between sleep, screen time, active school travel, sports/exercise participation and physical activity in children and adolescents

Study protocol

Cluster-randomised trial on participatory community-based outdoor physical activity promotion programs in adults aged 65–75 years in Germany: protocol of the OUTDOOR ACTIVE intervention trial

Research article

Stigma reduction in relation to HIV test uptake in low- and middle-income countries: a realist review